80 Results for "

antileukemic activity

" in MedChemExpress (MCE) Product Catalog:
Products (80)

80 Results for "antileukemic activity" in MCE Product Catalog:

Cat. No.: HY-149334
CAS No.: 2980653-93-6
Purity:  99.87%
ZLD115 (compound 44) is a FB23-derivated inhibitor of Fat Mass and Obesity-associated Protein (FTO). ZLD115 is an antileukemic agent, exhibiting antiproliferative activity against leukemic cell lines .
loading...
    loading...
Cat. No.: HY-15003
CAS No.: 853299-52-2
Purity:  99.54%
Target:  

FLT3 Apoptosis

Research Areas:  

Cancer

ATH686 is a potent, selective and ATP-competitive FLT3 inhibitor. ATH686 target mutant FLT3 protein kinase activity and inhibit the proliferation of cells harboring FLT3 mutants via induction of apoptosis and cell cycle inhibition. ATH686 has antileukemic effects .
loading...
    loading...
Cat. No.: HY-123955
CAS No.: 2079069-01-3
Purity:  99.26%
Research Areas:  

Cancer

Casein Kinase inhibitor A86 is a potent and orally active casein kinase 1α (CK1α) inhibitor. Casein Kinase inhibitor A86 also inhibits of CDK7 (TFIIH) and CDK9 (P-TEFb). Casein Kinase inhibitor A861 induces leukemia cell apoptosis, and has potent anti-leukemic activities .
loading...
    loading...
Cat. No.: HY-N8146
CAS No.: 53729-52-5
Bruceantinol is a quassinoid that can be isolated from Brucea javanica, inhibits pepper mottle virus (PepMoV) in pepper. Bruceantinol is a STAT3 inhibitor demonstrating potent antitumor activity in in vitro and in vivo human colorectal cancer (CRC) models. Bruceantinol has potent anti-leukemic activity. Bruceantinol strongly inhibits STAT3 DNA-binding ability (IC50 = 2.4 pM), blocks the constitutive and IL-6-induced STAT3 activation, and suppresses transcription of MCL-1, PTTG1, survivin and c-Myc. Bruceantinol binds with CDK2/4/6 to facilitate protein degradation through proteasome pathway. Bruceantinol can dose- and time-dependently reduces the cell growth, impede cell proliferation, disrupts the cell cycle, and induces necrosis in MCF-7 cells and apoptosis in MDA-MB-231 cells .
loading...
    loading...
Cat. No.: HY-123523
CAS No.: 55726-47-1
Purity:  99.32%
Enocitabine is a nucleoside analog, and is a potent DNA replication inhibitor, and a DNA chain terminator. Enocitabine inhibits the replication of human cytomegalovirus. Enocitabine has antileukemic and antiviral activities .
loading...
    loading...
Cat. No.: HY-141430
CAS No.: 2323623-80-7
Purity:  98.96%
Research Areas:  

Cancer

AS-85 is a potent ASH1L histone methyltransferase inhibitor (IC50=0.6 μM) with anti-leukemic activity. AS-85 strongly binds to the ASH1L SET domain, with the Kd value of 0.78 μM .
loading...
    loading...
Cat. No.: HY-153495
CAS No.: 202484-91-1
Synonyms: BP1001
Prexigebersen (BP1001) is an antisense oligonucleotide targeting Bcl-2 and Grb2. Prexigebersen exhibits antileukemic activity in cell models. Prexigebersen induces apoptosis (apoptosis), cell cycle arrest and ROS production in leukemia cells. Prexigebersen inhibits Grb2 expression, thereby suppressing tumor growth and survival. Prexigebersen can be used in studies related to acute myeloid leukemia .
loading...
    loading...
Cat. No.: HY-109179A
CAS No.: 2409543-84-4
Purity:  99.43%
Synonyms: TP-0184 hydrochloride
Itacnosertib hydrochloride (TP-0184 hydrochloride) is the inhibitor for FLT3, ACVR1 (ALK2, IC50=8 nM) and JAK2 (IC50=8540 nM). Itacnosertib hydrochloride exhibits anti-leukemic activity .
loading...
    loading...
Cat. No.: HY-120997
CAS No.: 114784-59-7
Synonyms: Berbamine p-nitrobenzoate
E6 Berbamine (Berbamine p-nitrobenzoate) is a potent calmodulin (CaM) antagonist. E6 Berbamine inhibits the activities of calmodulin-dependent myosin light chain kinase (MLCK) and phosphodiesterase (PDE). E6 Berbamine exhibits anti-leukemic activity. E6 Berbamine can be used in research related to cardiovascular abnormalities and chronic myeloid leukemia .
loading...
    loading...
Cat. No.: HY-174367
CAS No.: 923865-06-9
Target:  

RUNX Apoptosis

Research Areas:  

Cancer

RUNX1/ETO-IN-1 is a RUNX1-ETO oncogenic fusion protein inhibitor that specifically targets the NHR2 oligomerization domain. RUNX1/ETO-IN-1 directly interacts with the NHR2 (KD,app = 39 μM). RUNX1/ETO-IN-1 exhibits anti-leukemic activity by inducing apoptosis and promoting differentiation in RUNX1/ETO-translocated AML cells. RUNX1/ETO-IN-1 remains essentially uncharged at physiological pH, demonstrating superior membrane permeability.
loading...
    loading...
Cat. No.: HY-133900
CAS No.: 36804-95-2
Target:  

Others

Research Areas:  

Cancer

Deoxyharringtonine is an alkaloid isolated from Cephalotaxus genus with significant anti-leukemic activity .
loading...
    loading...
Cat. No.: HY-111008A
CAS No.: 95933-75-8
Synonyms: VF-233 hydrochloride
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

Trimidox hydrochloride (VF-233) is a ribonucleotide reductase inhibitor with antileukemic activities. Trimidox hydrochloride inhibits the growth of human promyelocytic leukemia HL-60 cells with an IC50 of 35 μM .
loading...
    loading...
Cat. No.: HY-111275
CAS No.: 857064-42-7
Target:  

JAK STAT Apoptosis Caspase PARP

Research Areas:  

Cancer

WP-1034 is a JAK-STAT inhibitor with proapoptotic and antileukemic activity in acute myeloid leukemia (AML). WP-1034 blocks activation of Stat 3 and 5. WP-1034 induces cell cycle arrest and triggers apoptosis. WP-1034 can be used for AML research .
loading...
    loading...
Cat. No.: HY-157327
CAS No.: 2566525-18-4
Purity:  98.29%
Target:  

Bcr-Abl

Research Areas:  

Cancer

AKE-72 (compound 5) is a potent inhibitor of Pan-BCR-ABL. AKE-72 inhibits BCR-ABL WT, BCR-ABL T315, BCR-ABL E255K, BCR-ABL F3171, BCR-ABL H396P and BCR-ABL Q252H with IC50s of < 0.5, 9, 8.98, 3.12, < 1.0 and 3.88 nM, respectively. AKE-72 has anti-leukemic activity against K-562 cell line .
loading...
    loading...
Cat. No.: HY-U00095R
CAS No.: 96892-57-8
Synonyms: NCI 329680 (Standard); ZINC01574758 (Standard)
Research Areas:  

Cancer

Hepsulfam (NCI 329680; ZINC01574758) is a anticancer agent that shows excellent antileukemic activity with an median IC50 of 0.91 μg/mL in a panel of different tumors.
loading...
    loading...
Cat. No.: HY-N17612
CAS No.: 366477-44-3
Haplophytin-A is a quinoline alkaloid. Haplophytin-A is a potent apoptosis inducer that exerts robust anti-leukemic activity by activating the caspase-8-dependent apoptotic pathway. Haplophytin-A can be used for the research of promyelocytic leukemia .
loading...
    loading...
Cat. No.: HY-115754
CAS No.: 53330-02-2
Synonyms: PEITC-Cys
Research Areas:  

Cancer

S-(N-PhenethylthiocarbaMoyl)-L-cysteine (PEITC-Cys), an anticarcinogenic agent, has antileukemic activity. S-(N-PhenethylthiocarbaMoyl)-L-cysteine inhibits DNA synthesis in HL60 cells . S-(N-PhenethylthiocarbaMoyl)-L-cysteine is a P450 inhibitor .
loading...
    loading...
Cat. No.: HY-160787
CAS No.: 2193085-94-6
Target:  

FLT3 IRAK

Research Areas:  

Cancer

NCGC1481 is an inhibitor of FLT3, IRAK1, and IRAK4, with IC50 values of <0.5 nM, 22.6 nM, and 0.8 nM, respectively. NCGC1481 can effectively overcome the adaptive resistance of leukemia cells to FLT3 inhibitors and has antileukemic activity .
loading...
    loading...
Cat. No.: HY-107338
CAS No.: 51287-57-1
Synonyms: Vratizolin; Wratizolin
Denotivir (Vratizolin) is an orally active antiviral agent for herpes simplex virus (HSV) and varicella-zoster virus (VZV). Denotivir inhibits the proliferation of various cancer cells, and exhibits anti-leukemic activity. Denotivir inhibits the generation of TNF-α, IL-1 and IL-6, exhibits immunosuppressive efficacy .
loading...
    loading...
Cat. No.: HY-141429C
Research Areas:  

Cancer

AS-99 is a first-in-class, potent, and selective ASH1L histone methyltransferase inhibitor (IC50= 0.79 μM, Kd= 0.89 μM) with anti-leukemic activity. AS-99 blocks cell proliferation, induces apoptosis and differentiation, downregulates MLL fusion target genes, and reduces the leukemia burden in vivo .
loading...
    loading...